Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.55
-0.04 (-0.72%)
At close: Oct 26, 2026, 4:00 PM EDT
5.41
-0.14 (-2.52%)
Pre-market: Oct 27, 2026, 4:22 AM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $333.58 million as of October 26, 2026. It is the 17,363rd most valuable company in the world and the 3,070th biggest in the United States. Its market cap has increased by 56.13% in one year.
Market Cap
333.58M
Enterprise Value
294.38M
1-Year Change
56.13%
Global Rank
Country Rank
#3,070 United States
Category
ChartMarket Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $333.58M, an increase of 68.95%. That is a compound annual growth rate of 8.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 333.58M | 42.36% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 355.93M |
| Enanta Pharmaceuticals | 349.50M |
| Relmada Therapeutics | 344.54M |
| Zura Bio | 341.15M |
| Capricor Therapeutics | 333.72M |
| Atea Pharmaceuticals | 333.65M |
| Kyverna Therapeutics | 325.91M |
| X4 Pharmaceuticals | 322.23M |